DekaBank Deutsche Girozentrale’s Tvardi Therapeutics TVRD Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-450	Closed	-$246K	–	1494
2021 Q3	$246K	Hold	450	–	–	﹤0.01%	1169
2021 Q2	$229K	Hold	450	–	–	﹤0.01%	1196
2021 Q1	$329K	Hold	450	–	–	﹤0.01%	1099
2020 Q4	$244K	Hold	450	–	–	﹤0.01%	1150
2020 Q3	$197K	Buy	+450	New	+$261K	﹤0.01%	1053
2020 Q1	–	Sell	-1,319	Closed	-$776K	–	1165
2019 Q4	$776K	Sell	1,319 -167	-11%	-$117K	﹤0.01%	743
2019 Q3	$997K	Sell	1,486 -167	-10%	-$139K	0.01%	667
2019 Q2	$1.26M	Buy	1,653 +1,278	+341%	+$898K	0.01%	736
2019 Q1	$270K	Buy	375 +69	+23%	+$41.3K	﹤0.01%	1002
2018 Q4	$143K	Sell	306 -69	-18%	-$44.5K	﹤0.01%	1015
2018 Q3	$270K	Hold	375	–	–	﹤0.01%	1024
2018 Q2	$260K	Hold	375	–	–	﹤0.01%	1011
2018 Q1	$164K	Buy	+375	New	+$182K	﹤0.01%	1014
2016 Q1	–	Sell	-383	Closed	-$218K	–	1104
2015 Q4	$218K	Buy	383 +2	+0.5%	+$1.1K	﹤0.01%	848
2015 Q3	$196K	Buy	381 +67	+21%	+$44.9K	﹤0.01%	879
2015 Q2	$137K	Buy	314 +22	+8%	+$8.5K	﹤0.01%	976
2015 Q1	$106K	Buy	+292	New	+$111K	﹤0.01%	993

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TVRD Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Tvardi Therapeutics (TVRD) in Q4 2021, closing a stake of 450 shares — an estimated $246K sold.

DekaBank Deutsche Girozentrale first reported a position in TVRD in Q1 2015 and held it in 17 quarters. The position peaked at $1.26M in Q2 2019. 181 funds tracked by Wall St. Rank hold TVRD as of Q4 2021.

DekaBank Deutsche Girozentrale reported no remaining Tvardi Therapeutics position as of Q4 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 450 Tvardi Therapeutics shares in Q4 2021, an estimated $246K.
DekaBank Deutsche Girozentrale first reported a position in Tvardi Therapeutics in Q1 2015 and held it in 17 quarters.
DekaBank Deutsche Girozentrale's Tvardi Therapeutics position peaked at $1.26M in Q2 2019.
181 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.